1. AB0468 Possible effects of belimumab therapy on t- and b-cell phenotype in a cohort of patients with systemic lupus erythematosus. (15th June 2017) Authors: Piantoni, S; Regola, F; Scarsi, M; Dall'Ara, F; Andreoli, L; Tincani, A; Airò, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes. (January 2018) Authors: Piantoni, S; Regola, F; Zanola, A; Andreoli, L; Dall'Ara, F; Tincani, A; Airo', P Journal: Lupus Issue: Volume 27:Number 1(2018) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0249 Circulating follicular helper-like t cells in patients with rheumatoid arthritis treated with abatacept. (15th June 2017) Authors: Piantoni, S; Scarsi, M; Regola, F; Tincani, A; Airò, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P036 B cell number reduction has a predictive value for response to belimumab in a cohort of patients with systemic lupus erythematosus. (March 2019) Authors: Piantoni, S; Andreoli, L; Lowin, T; Kumar, R; Regola, F; Airò, P; Cavazzana, I; Franceschini, F; Tincani, A; Pongratz, G Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P038 Recent thymic emigrant t cells increase in rheumatoid patients treated with abatacept. (21st February 2018) Authors: Piantoni, S; Regola, F; Tincani, A; Airò, P Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO.2.29 Serum levels of b-cell related factors belonging to the tnf/tnfr superfamily are lower in antiphospholipid-related syndromes than in systemic lupus erythematosus. (27th September 2022) Authors: Piantoni, S; Regola, F; Lowin, T; Bertocchi, S; Pedretti, E; Tamanini, S; Tincani, A; Franceschini, F; Andreoli, L; Pongratz, G Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S7A:6 Baseline serum levels of baff or april are independent predictors of sledai response after 12 months of treatment with belimumab in patients with refractory systemic lupus erythematosus. (21st March 2018) Authors: Piantoni, S; Andreoli, L; Lowin, T; Kumar, R; Regola, F; Airò, P; Franceschini, F; Tincani, A; Pongratz, G Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗